Skip to main content
TipRanks
Go Ultimate75% OFF

SK Biopharmaceuticals Co., Ltd. (326030) Balance Sheet

SK Biopharmaceuticals Co., Ltd. Balance Sheet

SK Biopharmaceuticals Co., Ltd.'s total assets for Q2 2026 were ₩1.42T, an increase of 7.45% from the previous quarter. KR:326030 total liabilities were ₩397.00B for the fiscal quarter, a 2.22% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
₩ 1.20T₩ 1.04T₩ 723.17B₩ 664.24B₩ 643.65B
₩ 372.04B₩ 462.83B₩ 402.22B₩ 347.68B₩ 199.46B
₩ 826.27B₩ 573.98B₩ 320.95B₩ 316.56B₩ 444.19B

Currency in KRW

SK Biopharmaceuticals Co., Ltd. Liabilities to Assets

0500B1T1.5T0 %40 %80 %120 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets